SEATTLE, March 13, 2017 /PRNewswire/ -- Diego Pellicer Worldwide, Inc. a real estate and consumer retail developmentcompany that is focused on developing the world's first "premium" cannabis brand, today announced a first in the Company's history of operations.
Our branded tenants have secured multiple state cannabis licenses, including medical and recreational cultivation licenses, infused medical and recreational products manufacturer licenses (Medical Processor License for edibles and concentrates), and retail licenses.
Ron Throgmartin, CEO of Diego Pellicer Worldwide, stated, "The cannabis consumer will experience unparalleled customer service, selection and pricing from our branded tenant's, as Diego Pellicer redefines the cannabis shopping experience. With rent commencing in all of our branded locations, Diego Pellicer can now focus on expansion and new acquisitions, as we increase our market share, and follow our growth strategy, to drive shareholder value."
The full third quarter 2016 report for Diego Pellicer is be available on the SEC website at https://www.sec.gov/.
About Diego Pellicer WorldwideDiego Pellicer Worldwide, Inc. is a real estate and consumer retail development company that is focused on developing Diego Pellicer as the world's first "premium" marijuana brand. Through the development and acquisition of premium, legally compliant real estate locations for cannabis growers and retailers, Diego Pellicer Worldwide provides a best-in-class platform for new business growth in the cannabis industry. Diego Pellicer does not grow or sell marijuana or marijuana infused products. For more information, please visit our website at http://DiegoPellicer.com/
Safe Harbor StatementCertain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of Diego Pellicer review its filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Investor Contacts: Nello Gonfiantini email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diego-pellicer-worldwide-recognizes-a-first-300422402.html
SOURCE Diego Pellicer Worldwide, Inc.
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...